Home › Occupations › Medical Scientists, Except Epidemiologists › Palo Alto, CA
Medical Scientists, Except Epidemiologists in Palo Alto, CA: H-1B salaries
57 labor condition applications for this occupation with a work site in Palo Alto, CA. Median offered base salary $85,000; middle half $77,688–$125,000.
By wage level
| Wage level | Median salary |
|---|---|
| Level I (entry) | $80,000 |
| Level II (qualified) | $104,998 |
| Level III (experienced) | $184,000 |
| Level IV (fully competent) | $169,146 |
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Employers
| Employer | LCAs | Median salary |
|---|---|---|
| The Leland Stanford, Jr University | 42 | $81,705 |
| Arc Research Institute | 2 | $125,000 |
| Jazz Pharmaceuticals, Inc. | 2 | $187,500 |
| Ascendis Pharma, Inc. | 2 | $247,800 |
| Vivo Capital,LLC | 2 | $169,146 |
| Bayshore Global Management LLC | 2 | — |
| Greenstone Biosciences, Inc. | 1 | — |
| ReCor Medical, Inc. | 1 | $113,006 |
| Yemaya, Inc. | 1 | $190,000 |
| Guardant Health, Inc. | 1 | $126,942 |
| LVIS Corporation | 1 | $150,613 |
Job titles
- Basic Life Research Scientist24
- Instructor7
- Postdoctoral Research Affiliate6
- Scientist2
- Head of Healthcare and Life Sciences2
- Senior Scientist1
- Director, Toxicology1
- Associate Director, Medical Safety Science1
- Head, Global PV Operations1
- Assc Director, DMPK (Drug Metabolism and Pharmacokinetics)1
- Asst Professor1
- Science Engineering Assoc 21
- Life Science Research Professional 11
- Life Science Rsch Prof 21
- Manager - Medical Affairs1
H-1B sponsors in Palo Alto, CA →
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).